Anmeldung erfolgt in Kürze...
Details werden geladen...
ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update | The Manila Times
2Q 2026 Total Revenue of $124.4 Million, Increasing 2% Year-over-Year
Ähnliche Seiten
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/05/tmt-newswire/globenewswire/syndax-reports-second-quarter-2026-financial-results-and-provides-business-update/2398415Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/07/tmt-newswire/globenewswire/ardelyx-reports-second-quarter-2026-financial-results-and-provides-business-update/2400541Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/07/tmt-newswire/globenewswire/gyre-therapeutics-reports-second-quarter-2026-and-year-to-date-financial-results-and-provides-business-update/2400915Immunocore reports second quarter financial results and provides a business update | The Manila Times
https://www.manilatimes.net/2026/08/06/tmt-newswire/globenewswire/immunocore-reports-second-quarter-financial-results-and-provides-a-business-update/2399911argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update | The Manila Times
https://www.manilatimes.net/2026/07/23/tmt-newswire/globenewswire/argenx-reports-half-year-2026-financial-results-and-provides-second-quarter-business-update/2389933